Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Origin Bancorp
OBK
$1.69B
| $769K | ﹤0.01% |
23,100
-4,800
| -17% | -$161K |
|
|
MURA
2627
DELISTED
Mural Oncology
MURA
| $768K | ﹤0.01% |
238,465
+35,403
| +17% | +$125K |
|
2628
iShares MSCI Saudi Arabia ETF
KSA
$624M
| $768K | ﹤0.01% |
18,800
-16,100
| -46% | -$669K |
|
|
TBCH
2629
Turtle Beach Corp
TBCH
$269M
| $766K | ﹤0.01% |
44,226
-82,402
| -65% | -$1.35M |
|
2630
Rocky Mountain Chocolate Factory
RMCF
$7.93M
| $764K | ﹤0.01% |
314,223
-2,756
| -0.9% | -$7.02K |
|
2631
Outset Medical
OM
$94.9M
| $762K | ﹤0.01% |
45,783
+42,171
| +1,168% | +$526K |
|
2632
Superior Group of Companies
SGC
$216M
| $762K | ﹤0.01% |
46,100
-26,300
| -36% | -$422K |
|
2633
Pulmatrix
PULM
$6.03M
| $762K | ﹤0.01% |
109,120
-8,100
| -7% | -$33.4K |
|
2634
West Fraser Timber
WFG
$5.5B
| $762K | ﹤0.01% |
8,800
-8,200
| -48% | -$768K |
|
|
ZEUS
2635
DELISTED
Olympic Steel
ZEUS
| $761K | ﹤0.01% |
23,200
-56,198
| -71% | -$2.18M |
|
2636
Elanco Animal Health
ELAN
$13.1B
| $760K | ﹤0.01% |
62,767
-416,777
| -87% | -$5.45M |
|
2637
ECB Bancorp
ECBK
$181M
| $760K | ﹤0.01% |
51,200
-200
| -0.4% | -$2.99K |
|
2638
Green Plains
GPRE
$1.15B
| $754K | ﹤0.01% |
79,529
+4,200
| +6% | +$47.3K |
|
2639
Protara Therapeutics
TARA
$225M
| $751K | ﹤0.01% |
142,300
-194,440
| -58% | -$628K |
|
|
FVR
2640
FrontView REIT
FVR
$471M
| $751K | ﹤0.01% |
+41,400
| New | +$783K |
|
2641
iHeartMedia
IHRT
$576M
| $748K | ﹤0.01% |
377,600
+121,300
| +47% | +$257K |
|
2642
iShares US Energy ETF
IYE
$1.7B
| $747K | ﹤0.01% |
+16,400
| New | +$786K |
|
|
ONIT
2643
Onity Group
ONIT
$321M
| $747K | ﹤0.01% |
24,315
+16,815
| +224% | +$520K |
|
2644
Axos Financial
AX
$5.89B
| $746K | ﹤0.01% |
10,684
-98,116
| -90% | -$7.16M |
|
2645
FinWise Bancorp
FINW
$193M
| $746K | ﹤0.01% |
46,700
-1,800
| -4% | -$30.6K |
|
2646
CNX Resources
CNX
$5.11B
| $745K | ﹤0.01% |
20,316
-17,800
| -47% | -$656K |
|
|
BZUN
2647
Baozun
BZUN
$172M
| $743K | ﹤0.01% |
273,053
+76,537
| +39% | +$232K |
|
|
SHCO
2648
DELISTED
Soho House & Co
SHCO
| $742K | ﹤0.01% |
+99,642
| New | +$543K |
|
|
FBMS
2649
DELISTED
The First Bancshares, Inc.
FBMS
| $742K | ﹤0.01% |
21,200
-32,800
| -61% | -$1.14M |
|
2650
abrdn Physical Palladium Shares ETF
PALL
$661M
| $740K | ﹤0.01% |
+44,320
| New | +$822K |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.